עקוב אחר
Dr. Laila C. Roisman
Dr. Laila C. Roisman
Shaare Zedek Medical Center
כתובת אימייל מאומתת בדומיין post.bgu.ac.il
כותרת
צוטט על ידי
צוטט על ידי
שנה
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
QZ Tuo, P Lei, KA Jackman, XL Li, H Xiong, ZY Liuyang, L Roisman, ...
Molecular psychiatry 22 (11), 1520-1530, 2017
5132017
Inquiring into the differential action of interferons (IFNs): an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β
DA Jaitin, LC Roisman, E Jaks, M Gavutis, J Piehler, J Van der Heyden, ...
Molecular and cellular biology 26 (5), 1888-1897, 2006
2612006
DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention
T Paz-Elizur, Z Sevilya, Y Leitner-Dagan, D Elinger, LC Roisman, ...
Cancer letters 266 (1), 60-72, 2008
2532008
Interferon-ε protects the female reproductive tract from viral and bacterial infection
KY Fung, NE Mangan, H Cumming, JC Horvat, JR Mayall, SA Stifter, ...
Science 339 (6123), 1088-1092, 2013
2442013
New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface
J Piehler, LC Roisman, G Schreiber
Journal of biological chemistry 275 (51), 40425-40433, 2000
2212000
BRAF mutant lung cancer: programmed death ligand 1 expression, tumor mutational burden, microsatellite instability status, and response to immune check-point inhibitors
E Dudnik, N Peled, H Nechushtan, M Wollner, A Onn, A Agbarya, ...
Journal of Thoracic Oncology 13 (8), 1128-1137, 2018
1962018
A molecular basis for NKT cell recognition of CD1d-self-antigen
T Mallevaey, AJ Clarke, JP Scott-Browne, MH Young, LC Roisman, ...
Immunity 34 (3), 315-326, 2011
1492011
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking
LC Roisman, J Piehler, JY Trosset, HA Scheraga, G Schreiber
Proceedings of the National Academy of Sciences 98 (23), 13231-13236, 2001
1382001
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: the real-life data
E Dudnik, M Moskovitz, S Daher, S Shamai, E Hanovich, A Grubstein, ...
Lung cancer 126, 217-223, 2018
1112018
Mutational analysis of the IFNAR1 binding site on IFNα2 reveals the architecture of a weak ligand–receptor binding-site
LC Roisman, DA Jaitin, DP Baker, G Schreiber
Journal of molecular biology 353 (2), 271-281, 2005
1032005
The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96‐110
F Corrigan, E Thornton, LC Roisman, AV Leonard, R Vink, PC Blumbergs, ...
Journal of neurochemistry 128 (1), 196-204, 2014
632014
N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk
Y Leitner-Dagan, Z Sevilya, M Pinchev, R Kramer, D Elinger, LC Roisman, ...
Journal of the National Cancer Institute 104 (22), 1765-1769, 2012
572012
Subclonal therapy by two EGFR TKIs guided by sequential plasma cell-free DNA in EGFR-mutated lung cancer
N Peled, LC Roisman, B Miron, R Pfeffer, RB Lanman, M Ilouze, A Dvir, ...
Journal of Thoracic Oncology 12 (7), e81-e84, 2017
532017
Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
E Dudnik, E Bshara, A Grubstein, L Fridel, T Shochat, LC Roisman, ...
Lung Cancer 124, 117-124, 2018
512018
Rare Variants of ATM and Risk for Hodgkin’s Disease and Radiation-associated Breast Cancers
K Offit, S Gilad, S Paglin, P Kolachana, LC Roisman, K Nafa, ...
Clinical cancer research 8 (12), 3813-3819, 2002
482002
Lung cancer in young patients: higher rate of driver mutations and brain involvement, but better survival
AM Suidan, L Roisman, AB Rozenblum, M Ilouze, E Dudnik, A Zer, ...
Journal of global oncology 5, 2019
442019
The clinical impact of comprehensive genomic testing of circulating cell-free DNA in advanced lung cancer
S Laufer-Geva, AB Rozenblum, T Twito, R Grinberg, A Dvir, ...
Journal of Thoracic Oncology 13 (11), 1705-1716, 2018
422018
GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients
N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ...
Lung Cancer 148, 48-54, 2020
262020
Optimizing the binding affinity of a carrier protein: A case study on the interaction between soluble ifnar2 and interferon β
T Peleg-Shulman, LC Roisman, G Zupkovitz, G Schreiber
Journal of Biological Chemistry 279 (17), 18046-18053, 2004
262004
The impact of osimertinib’line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance
V Fuchs, L Roisman, W Kian, L Daniel, J Dudnik, H Nechushtan, ...
Lung Cancer 153, 126-133, 2021
202021
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20